Inorganic Chemistry at the Frontier of Immunotherapy - Björn Schimmöller - #15

Inorganic Chemistry at the Frontier of Immunotherapy - Björn Schimmöller - #15

In this episode, we speak with ⁠⁠Björn Schimmöller, Co-Founder and CEO of iuvantium, a synthetic immunobiology company developing new modalities for the next generation of immunotherapies.

Host: ⁠⁠Murat Tunaboylu⁠⁠, Co-Founder and CEO of Antiverse.

You will learn:

  • The founding journey of iuvantium from Oxford University.
  • How Iuvantium is enhancing immune system efficiency and reducing clinical trial uncertainty using inorganic chemistry.
  • ‘Decoding’ the immune system and how personalised medicine may lead to the next leaps in immunotherapy.

Things mentioned:

Additional Materials:

First time hearing about Antiverse?

Antiverse is an artificial intelligence-driven techbio company that specialises in antibody design against difficult-to-drug targets, including G-protein coupled receptors (GPCRs) and ion channels. Headquartered in Cardiff, UK and with offices in Boston, MA, Antiverse combines state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. With a primary focus on establishing long-term partnerships, Antiverse has collaborated with two top 20 global pharmaceutical companies. In addition, they are developing a strong internal pipeline of antibodies against several challenging drug targets across various indications.

For more information, please visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.antiverse.io⁠⁠

Never miss a future event!

We'll notify you when a new event is scheduled. Fill out ⁠⁠⁠⁠⁠⁠this form⁠⁠⁠⁠⁠⁠ to sign up for marketing communications from Antiverse. We post about upcoming events on LinkedIn and Twitter.

LinkedIn: ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/antiverse/⁠⁠⁠⁠⁠⁠

X: ⁠⁠⁠⁠⁠⁠https://twitter.com/AntiverseHQ⁠⁠

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(18)

AI Statistical Programming for FDA Submissions - Louise Liu - #18

AI Statistical Programming for FDA Submissions - Louise Liu - #18

In this episode of Future of Drug Discovery, we speak with Louise Liu, Founder and CEO of Hill Research. The statistical programming behind an FDA submission is one of the slower steps in clinical dev...

20 Maj 25min

Rahmad Akbar - Frontiers of AI Antibody Design (FODD #17)

Rahmad Akbar - Frontiers of AI Antibody Design (FODD #17)

This episode is a discussion between ⁠Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk and Murat Tunaboylu⁠, Co-Founder and CEO of Antiverse⁠. You will learn: The impact anti...

3 Sep 202426min

Paul Essery and Murat Tunaboylu - Founding an AI Drug Discovery Start-Up (FODD #16)

Paul Essery and Murat Tunaboylu - Founding an AI Drug Discovery Start-Up (FODD #16)

This episode is a discussion between Paul Essery, Host of 'The Tech Business Podcast' and Murat Tunaboylu Co-Founder and CEO of Antiverse. You will learn: The CEO journey and how Antiverse was fou...

23 Juli 202414min

AI, Automation and Drug Discovery - Ashwini Ghogare - #14

AI, Automation and Drug Discovery - Ashwini Ghogare - #14

In this episode, we speak with ⁠Ashwini Ghogare⁠, Head of Artificial Intelligence and Automation in Drug Discovery at ⁠MilliporeSigma⁠, the Global Science and Technology Group at ⁠Merck⁠.Host: ⁠Murat ...

11 Dec 202326min

Unleashing the Power of Computational Biology - Ming 'Tommy' Tang - #13

Unleashing the Power of Computational Biology - Ming 'Tommy' Tang - #13

In this talk, Murat speaks with Ming (Tommy) Tang, Director of Computational Biology at Immunitas Therapeutics, an immuno-oncology start-up developing novel therapeutics for patients with cancer. Tomm...

20 Okt 202333min

Digital Foundations For Rapid Healthcare Advancement - Nikhil Reddy Podduturi - #12

Digital Foundations For Rapid Healthcare Advancement - Nikhil Reddy Podduturi - #12

In this talk, Murat speaks with ⁠Nikhil Podduturi⁠, Head of Data Science at the Digital Lab of ⁠Boehringer Ingelheim⁠ - ⁠(BI X)⁠.  Nikhil co-leads the laboratory and data science chapters at the BI X ...

6 Okt 202327min

Machine Learning Blueprints for Pharma Discovery Breakthroughs - Abhishek Pandey - #11

Machine Learning Blueprints for Pharma Discovery Breakthroughs - Abhishek Pandey - #11

In this talk, Murat speaks with Abhishek Pandey, Principle Research Scientist and Pharma Discovery Group Lead at AbbVie. Abhishek currently leads RAIDERS, a Pharma Discovery group integrating machine ...

2 Maj 202327min

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
rss-ufobortom-rimligt-tvivel
svd-nyhetsartiklar
medicinvetarna
det-morka-psyket
rss-spraket
rss-vetenskapsradion
halsorevolutionen
dumforklarat
sexet
bildningspodden
vetenskapsradion
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
rss-vetenskapsradion-2
paranormalt-med-caroline-giertz
4health-med-anna-sparre
rss-ronden